Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Zhang

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Chemical Information and Modeling|December 17, 2025
Toward Complete Molecular Structure Prediction from Infrared Spectroscopy Using Deep LearningColin Zhang, Yang Ha
ACS Applied Bio Materials|May 2, 2024
3D Bioprinting of Sugar Beet Pectin through Horseradish Peroxidase-Catalyzed Cross-LinkingWildan Mubarok, Colin Zhang, Shinji Sakai
Biofabrication|December 5, 2025
AI-powered printability evaluation framework for 3D bioprinting using Hausdorff distance metricsColin Zhang, Kelum Chamara Manoj Lakmal Elvitigala, Shinji Sakai
Scientific Reports|March 7, 2025
Physics-informed machine learning for automatic model reduction in chemical reaction networksJoseph Pateras, Colin Zhang, Shriya Majumdar, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionDavid M Burns, Yun-Long Li, Eric Shi, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2Minh H Nguyen, Onur Atasoylu, Liangxing Wu, et al.
Journal of Medicinal Chemistry|July 16, 2021
Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) InhibitorLiangxing Wu, Colin Zhang, Chunhong He, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2007
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosisWenqing Yao, Jincong Zhuo, David M Burns, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2022
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approachColin Zhang, Meizhong Xu, Chunhong He, et al.
Cancer Biology & Therapy|April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cellsPhillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Chemical Information and Modeling|December 17, 2025
Toward Complete Molecular Structure Prediction from Infrared Spectroscopy Using Deep LearningColin Zhang, Yang Ha
ACS Applied Bio Materials|May 2, 2024
3D Bioprinting of Sugar Beet Pectin through Horseradish Peroxidase-Catalyzed Cross-LinkingWildan Mubarok, Colin Zhang, Shinji Sakai
Biofabrication|December 5, 2025
AI-powered printability evaluation framework for 3D bioprinting using Hausdorff distance metricsColin Zhang, Kelum Chamara Manoj Lakmal Elvitigala, Shinji Sakai
Scientific Reports|March 7, 2025
Physics-informed machine learning for automatic model reduction in chemical reaction networksJoseph Pateras, Colin Zhang, Shriya Majumdar, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionDavid M Burns, Yun-Long Li, Eric Shi, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2Minh H Nguyen, Onur Atasoylu, Liangxing Wu, et al.
Journal of Medicinal Chemistry|July 16, 2021
Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) InhibitorLiangxing Wu, Colin Zhang, Chunhong He, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2007
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosisWenqing Yao, Jincong Zhuo, David M Burns, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2022
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approachColin Zhang, Meizhong Xu, Chunhong He, et al.
Cancer Biology & Therapy|April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cellsPhillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Pageof 2